Athenex Inc
Change company Symbol lookup
Select an option...
ATNX Athenex Inc
ALGN Align Technology Inc
PPG PPG Industries Inc
VFFVX Vanguard Target Retirement 2055 Fund Investor Shares
LUB Luby's Inc
AZO Autozone Inc
RMAX Re/Max Holdings Inc
SWET Athlon Acquisition Corp
ETR Entergy Corp
KUBTY Kubota Corp
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Athenex, Inc. is an oncology pharmaceutical company focused on the development and commercialization of therapies for cancer diseases and supportive therapies. The Company's technology platform is organized into three categories, including Oral Absorption Platform, Src Kinase Inhibitors and Symptom Therapeutics. The Company offers Oraxol, an oral formulation of paclitaxel; Orateacan, an oral formulation of Irinotecan; Oradoxel, an oral formulation of Docetaxel, and an oral formulation of Topotecan for the treatment of various types of cancers. Its Src Kinase Inhibitors include KX-01 (KX2-391) and KX-02 (KX2-361) oncology drug candidates. The Company's Symptom Therapeutics include CQ-01, which is used for the treatment of burn pruritus and scars; CQ-R1, which is used for the treatment of an irradiation-induced dermatitis, and an intranasal Granisetron used for the treatment of chemotherapy-induced nausea/vomiting.

Postmarket

Last Trade
Delayed
$3.95
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$3.95
Day's Change
-0.02 (-0.50%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
4.12
Day's Low
3.88
Volume
(Below Average)
Volume:
1,769,984

10-day average volume:
1,972,954
1,769,984
  • Prev Close
    3.97
  • Today's Open
    4.12
  • Day's Range
    3.88-4.12
  • Avg Vol (10-day)
    2.0M
  • Last (time)
    4:00p ET 04/19/21
  • Last (size)
    6
  • 52-Wk Range
    3.76 - 15.24
    LowHigh
  • (09/08/20 - 04/13/21)
    5.05%
  • 103.0%
  • Market Cap
    369.1M
  • Shares Outstanding
    93.5M
  • -1.70
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.6
  • 62.05
  • (% of float 03/31/21)
    21.49

Latest News

April 19, 2021
2:01 pm ET
Accesswire
1:20 pm ET
Globe Newswire
11:41 am ET
Accesswire
11:00 am ET
Accesswire
6:30 am ET
Accesswire
April 17, 2021
1:45 pm ET
Globe Newswire
April 16, 2021
11:23 pm ET
Accesswire
5:52 pm ET
Newsfile
4:25 pm ET
Accesswire
3:17 pm ET
Accesswire
2:30 pm ET
Accesswire
12:02 pm ET
Accesswire
11:35 am ET
PR Newswire
April 15, 2021
5:05 pm ET
Accesswire
4:40 pm ET
Accesswire
6:30 am ET
Accesswire
April 14, 2021
11:07 pm ET
Globe Newswire
5:54 pm ET
Accesswire
5:01 pm ET
Newsfile
4:39 pm ET
Accesswire
4:00 pm ET
Globe Newswire
11:30 am ET
Accesswire
11:22 am ET
Globe Newswire
11:01 am ET
Accesswire
April 13, 2021
6:14 pm ET
Accesswire
5:35 pm ET
Globe Newswire
12:51 pm ET
Accesswire
7:31 am ET
Accesswire
6:45 am ET
PR Newswire
April 12, 2021
9:43 pm ET
Newsfile
8:16 pm ET
Newsfile
7:51 pm ET
Accesswire
7:14 pm ET
Globe Newswire
1:25 pm ET
Accesswire
10:30 am ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.